A chemist in the SFB Polytarget uses a pipette to introduce cell samples into a microtitre plate. Image: Jan-Peter Kasper (University of Jena)
A chemist in the SFB Polytarget uses a pipette to introduce cell samples into a microtitre plate. Image: Jan-Peter Kasper (University of Jena) - Collaborative Research Centre "PolyTarget" receives German Research Foundation funding for second phase worth close to 15 million euros Life Medicines usually have side effects because they have to be administered in higher doses to make sure that the active substance reaches the place where it is needed. Researchers at Friedrich Schiller University Jena have therefore dedicated themselves to the search for alternative carrier materials. Since 2017, in the Collaborative Research Centre (CRC) "PolyTarget", they have been developing systems that guide medicines straight to their destination and deliver the active substances exactly where they are needed. The Jena scientists are supported in their work by the German Research Foundation, which has now approved further funding of nearly 15 million euros for the next four years. The CRC includes Jena researchers from the fields of chemistry, materials sciences, pharmacy and biochemistry, as well as doctors from Jena University Hospital and scientists from Jena's Leibniz Institutes on Photonic Technology, Natural Product Research and Infection Biology, and Aging, and also the University of Erlangen-Nürnberg. In the first funding phase, the CRC produced more than 200 publications, more than 110 of which were joint publications from multiple applicants.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
